Oruka Therapeutics (ORKA) News
NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
95.81-1.76 (-1.80%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ORKA news summary
We found 7 recent headlines mentioning Oruka Therapeutics (ORKA): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, ORKA is down 1.80% at $95.81. The most recent story, "Oruka Expects ORKA-001 52-Week Data In December; Phase 3 Start Planned For 2027", was published by Nasdaq on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Oruka Therapeutics headlines
- Oruka Expects ORKA-001 52-Week Data In December; Phase 3 Start Planned For 2027(RTTNews) - Oruka Therapeutics, Inc. (ORKA), a clinical-stage biotechnology company developing biologics for chronic skin diseases, reported third-quarter 2026 financial results Tuesday and provided…NasdaqORKA, HEI.A
- Three Movers And A Catalyst: SGRY, XNCR, ORKA Gain As Acumen Nears ALTITUDE-AD Readout(RTTNews) - Shares of several biotech companies moved sharply higher following corporate and clinical developments. Surgery Partners surged on reports of a late-stage buyout talks with Bon Secours…NasdaqABOS, ORKA, SGRY, XNCR
- Oruka Advances ORKA-001 Toward Phase 3 After Positive Psoriasis Data(RTTNews) - Oruka Therapeutics (ORKA) reported positive Week 16 Phase 2b EVERLAST-B results for ORKA-001 in moderate-to-severe psoriasis.NasdaqORKA, MOG.B
- Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026MENLO PARK, Calif., Oct. 25, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new…GlobeNewswire
- These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside AheadKey PointsRevolution Medicines recently made a breakthrough in oncology.NasdaqRVMD, ORKA
- XBI, TWST, ORKA, APGE: Large Inflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an…NasdaqXBI, TWST, ORKA
- 4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.NasdaqVNDA, PTGX, ALMS, ORKA